Industry sponsorship as meta-evidence: a simulation study

Abstract Industry funding is often indispensable to scientific research, but it can also introduce systematic biases that align study outcomes with commercial interests. Recent philosophical work suggests treating funding disclosures as meta-evidence: evidence about the evidential force of first-order study results. This paper asks whether such meta-evidence can be used to improve collective inquiry. Using an agent-based model, we compare two strategies for aggregating evidence in the presence of industry sponsorship: down-weighting industry-funded results and adjusting them relative to publicly funded studies. The simulations show that both strategies are highly context-sensitive. Relative adjustment can correct for bias when public evidence is reliable and sufficiently broad, but it falls short when public data are noisy or sparse. Down-weighting depends on a difficult and partly arbitrary choice of discount weight. The results suggest that industry sponsorship can be epistemically relevant meta-evidence without yielding a straightforward rule for evidence aggregation.

Authors

Institutions

Publication Details

Journal
European Journal for Philosophy of Science
Published
2026-10-30
DOI
https://doi.org/10.1007/s13194-026-00798-x
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Industry sponsorship as meta-evidence: a simulation study

Borut Trpin, Martin Justin
European Journal for Philosophy of Science
Pharmaceutical industry and healthcare
article

Industry sponsorship as meta-evidence: a simulation study

Borut Trpin, Martin Justin
article en

Abstract

Abstract Industry funding is often indispensable to scientific research, but it can also introduce systematic biases that align study outcomes with commercial interests. Recent philosophical work suggests treating funding disclosures as meta-evidence: evidence about the evidential force of first-order study results. This paper asks whether such meta-evidence can be used to improve collective inquiry. Using an agent-based model, we compare two strategies for aggregating evidence in the presence of industry sponsorship: down-weighting industry-funded results and adjusting them relative to publicly funded studies. The simulations show that both strategies are highly context-sensitive. Relative adjustment can correct for bias when public evidence is reliable and sufficiently broad, but it falls short when public data are noisy or sparse. Down-weighting depends on a difficult and partly arbitrary choice of discount weight. The results suggest that industry sponsorship can be epistemically relevant meta-evidence without yielding a straightforward rule for evidence aggregation.

European Journal for Philosophy of ScienceVol. 16(4)
University of Ljubljana (SI), University of Maribor (SI)
Javna Agencija za Raziskovalno Dejavnost RS
Openalex Percentile: Top 17%
Pharmaceutical industry and healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Industry sponsorship as meta-evidence: a simulation study — Borut Trpin, Martin Justin · European Journal for Philosophy of Science (2026) | TGRS Research Map | TGRS